Gene · 1585
Papers3,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 3,065
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Histopathological evidence of osilodrostat-induced regression of a cortisol-producing adrenocortical adenoma. | JCEM Case Rep | 2026 | 42158162 | PubTator, text mining | PubMed |
| Optimal Dose of Lorundrostat in Uncontrolled Hypertension: A Dose Response Meta-Analysis. | Dose Response | 2026 | 42130914 | PubTator, text mining | PubMed |
| Baxdrostat and Aldosterone Synthase Inhibitors: A New Class for Treatment-resistant Hypertension. | Cardiovasc Drugs Ther | 2026 | 42126470 | PubTator, text mining | PubMed |
| CVOT Summit Report 2025: advances along the cardiovascular-kidney-metabolic disease continuum. | Cardiovasc Diabetol | 2026 | 42092956 | PubTator, text mining | PubMed |
| Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence. | Clin Transplant | 2026 | 42090239 | PubTator, text mining | PubMed |
| Aldosterone synthase expression vs cross-sectional imaging in lateralized primary aldosteronism. | J Clin Endocrinol Metab | 2026 | 42089263 | PubTator, text mining | PubMed |
| Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup Analyses. | Diabetes Obes Metab | 2026 | 42086479 | PubTator, text mining | PubMed |
| TPD52 inhibits aldosterone synthesis through suppression of CAMKK2 signaling. | Eur J Endocrinol | 2026 | 42065138 | PubTator, text mining | PubMed |
| Management of hypertension in chronic kidney disease. | Clin Med (Lond) | 2026 | 42035931 | PubTator, text mining | PubMed |
| Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome. | Diabetes Obes Metab | 2026 | 42010373 | PubTator, text mining | PubMed |
| Clinical implications of 68Ga-pentixafor PET/CT in surgically treated primary aldosteronism. | Surgery | 2026 | 42001647 | PubTator, text mining | PubMed |
| Baxdrostat: A First-in-Class Aldosterone Synthase Inhibitor for Resistant Hypertension. | ACS Pharmacol Transl Sci | 2026 | 41988370 | PubTator, text mining | PubMed |
| Genetic Association of the Renin-Angiotensin-Aldosterone System with hypertension among the Malays and their adaptation to climate change. | PLoS One | 2026 | 41984970 | PubTator, text mining | PubMed |
| Resistant Hypertension: Pathophysiology, Diagnostic Approaches, and Emerging Therapeutic Strategies. | Curr Hypertens Rev | 2026 | 41969194 | PubTator, text mining | PubMed |
| Weekly Journal Scan: Aldosterone synthase inhibition with baxdrostat improves 24-hour blood pressure control in patients with treatment resistant hypertension. | Eur Heart J | 2026 | 41964449 | PubTator, text mining | PubMed |
| [Cardiovascular pharmacotherapy in the era of RNA-based precision medicine]. | Herz | 2026 | 41946839 | PubTator, text mining | PubMed |
| Efficacy and Safety of Baxdrostat in Resistant Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. | Cureus | 2026 | 41909295 | PubTator, text mining | PubMed |
| Congenital aldosterone deficiency and its resistance. | Endocr J | 2026 | 41905953 | PubTator, text mining | PubMed |
| A novel compound heterozygous mutation in CYP11B2 (p.A153P and p.Q337*) associated with primary hypoaldosteronism. | Front Med (Lausanne) | 2026 | 41889508 | PubTator, text mining | PubMed |
| Tspan4+ fibroblasts facilitate the development of NECSO in myocardial ischemia reperfusion through migrasomes-mediated Tnf-α autocrine and cardiomyocytes aldosterone generation. | Biochem Pharmacol | 2026 | 41887336 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1585/papers?page=4